BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24133572)

  • 1. Ensemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPARγ and TNFα signaling.
    Pagnotta SM; Laudanna C; Pancione M; Sabatino L; Votino C; Remo A; Cerulo L; Zoppoli P; Manfrin E; Colantuoni V; Ceccarelli M
    PLoS One; 2013; 8(8):e72638. PubMed ID: 24133572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
    Song Y; Song C; Yang S
    Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer.
    He J; Huang H; Du Y; Peng D; Zhou Y; Li Y; Wang H; Zhou Y; Nie Y
    Cell Oncol (Dordr); 2020 Jun; 43(3):409-420. PubMed ID: 32166582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Throughput Omics and Statistical Learning Integration for the Discovery and Validation of Novel Diagnostic Signatures in Colorectal Cancer.
    Long NP; Park S; Anh NH; Nghi TD; Yoon SJ; Park JH; Lim J; Kwon SW
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30642095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and clinical significance of serum NT5E protein in patients with colorectal cancer.
    Wang G; Fu S; Li D; Chen Y
    Cancer Biomark; 2019; 24(4):461-468. PubMed ID: 30932882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer.
    Xiong L; Wen Y; Miao X; Yang Z
    Cell Tissue Res; 2014 Feb; 355(2):365-74. PubMed ID: 24310606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
    Mini E; Lapucci A; Perrone G; D'Aurizio R; Napoli C; Brugia M; Landini I; Tassi R; Picariello L; Simi L; Mancini I; Messerini L; Magi A; Pinzani P; Mazzei T; Tonelli F; Nobili S
    Int J Cancer; 2019 Nov; 145(9):2580-2593. PubMed ID: 30973654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling.
    Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J
    BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systems Oncology Approach Identifies NT5E as a Key Metabolic Regulator in Tumor Cells and Modulator of Platinum Sensitivity.
    Nevedomskaya E; Perryman R; Solanki S; Syed N; Mayboroda OA; Keun HC
    J Proteome Res; 2016 Jan; 15(1):280-90. PubMed ID: 26629888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
    Milone MR; Pucci B; Colangelo T; Lombardi R; Iannelli F; Colantuoni V; Sabatino L; Budillon A
    Mol Oncol; 2016 Oct; 10(8):1344-62. PubMed ID: 27499265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
    Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
    Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The integrated pathway of TGFβ/Snail with TNFα/NFκB may facilitate the tumor-stroma interaction in the EMT process and colorectal cancer prognosis.
    Li H; Zhong A; Li S; Meng X; Wang X; Xu F; Lai M
    Sci Rep; 2017 Jul; 7(1):4915. PubMed ID: 28687755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-187, a downstream effector of TGFβ pathway, suppresses Smad-mediated epithelial-mesenchymal transition in colorectal cancer.
    Zhang F; Luo Y; Shao Z; Xu L; Liu X; Niu Y; Shi J; Sun X; Liu Y; Ding Y; Zhao L
    Cancer Lett; 2016 Apr; 373(2):203-13. PubMed ID: 26820227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT5E is associated with unfavorable prognosis and regulates cell proliferation and motility in gastric cancer.
    Hu S; Meng F; Yin X; Cao C; Zhang G
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems analysis identifies potential target genes to overcome cetuximab resistance in colorectal cancer cells.
    Park SM; Hwang CY; Cho SH; Lee D; Gong JR; Lee S; Nam S; Cho KH
    FEBS J; 2019 Apr; 286(7):1305-1318. PubMed ID: 30719834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
    Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
    JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.